Rectal cancer: Watch-and-wait and continuing the rectal-preserving strategy with local excision for incomplete response or limited regrowth

Verseveld, 2015, Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study), Br. J. Surg., 102, 853, 10.1002/bjs.9809 Bujko, 2013, Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor responders: a prospective multicentre study, Radiother. Oncol., 106, 198, 10.1016/j.radonc.2012.12.005 Jones, 2018, Modern management of T1 rectal cancer by transanal endoscopic microsurgery: a 10-year single-centre experience, Colorectal Dis., 20, 586, 10.1111/codi.14029 Sun Myint, 2017, Dose escalation using contact X-ray brachytherapy (Papillon) for rectal cancer: does it improve the chance of organ preservation?, Br. J. Radiol., 90, 20170175, 10.1259/bjr.20170175 Kapiteijn, 2001, Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer, N. Engl. J. Med., 345, 638, 10.1056/NEJMoa010580 Hartley, 2005, Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials, Br. J. Radiol., 78, 934, 10.1259/bjr/86650067 Appelt, 2015, High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study, Lancet Oncol., 16, 919, 10.1016/S1470-2045(15)00120-5 Ludmir, 2017, Total neoadjuvant therapy for rectal cancer: an emerging option, Cancer, 123, 1497, 10.1002/cncr.30600 Smith, 2015, BMC Canc., 15, 767, 10.1186/s12885-015-1632-z Habr-Gama, 2019, Organ preservation in cT2N0 rectal cancer after neoadjuvant chemoradiation therapy: the impact of radiation therapy dose-escalation and consolidation chemotherapy, Ann. Surg., 269(1), 102, 10.1097/SLA.0000000000002447 Habr-Gama, 2014, Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control, Int. J. Radiat. Oncol. Biol. Phys., 88, 822, 10.1016/j.ijrobp.2013.12.012 Habr-Gama, 2004, Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results, Ann. Surg., 240, 711, 10.1097/01.sla.0000141194.27992.32 Smart, 2016, Multicentre study of short-course radiotherapy and transanal endoscopic microsurgery for early rectal cancer, Br. J. Surg., 103, 1069, 10.1002/bjs.10171 Garcia-Aguilar, 2015, Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial, Lancet Oncol., 16, 1537, 10.1016/S1470-2045(15)00215-6 Fernandez, 2020, Salvage surgery with organ preservation for patients with local regrowth after watch and wait: is it still possible?, Dis. Colon Rectum, 63, 1053, 10.1097/DCR.0000000000001707 Perez, 2014, Transanal local excision for distal rectal cancer and incomplete response to neoadjuvant chemoradiation - does baseline staging matter?, Dis. Colon Rectum, 57, 1253, 10.1097/DCR.0000000000000215 Habr-Gama, 2016, Impact of organ-preserving strategies on anorectal function in patients with distal rectal cancer following neoadjuvant chemoradiation, Dis. Colon Rectum, 59, 264, 10.1097/DCR.0000000000000543 Jones, 2020, Quality of life after rectal-preserving treatment of rectal cancer, Eur. J. Surg. Oncol., 46, 2050, 10.1016/j.ejso.2020.07.018 Stijns, 2019, Long-term oncological and functional outcomes of chemoradiotherapy followed by organ-sparing transanal endoscopic microsurgery for distal rectal cancer: the CARTS study, JAMA Surg, 1, 47, 10.1001/jamasurg.2018.3752 Renehan, 2016, Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis, Lancet Oncol., 17, 174, 10.1016/S1470-2045(15)00467-2 van der Valk, 2018, Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study, Lancet, 391, 2537, 10.1016/S0140-6736(18)31078-X Owens, 2020, Intensity-modulated radiotherapy with a simultaneous integrated boost in rectal cancer, Clin. Oncol., 32, 35, 10.1016/j.clon.2019.07.009 Sammour, 2017, Nonoperative management or 'watch and wait' for rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy: a critical appraisal, Ann. Surg Oncol., 24, 1904, 10.1245/s10434-017-5841-3 Patel, 2012, MRI after treatment of locally advanced rectal cancer: how to report tumor response-the MERCURY experience, AJR Am. J. Roentgenol., 199, W486, 10.2214/AJR.11.8210 Vandenbroucke, 2007, Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration, PLoS Med., 4, e297, 10.1371/journal.pmed.0040297 São Julião, 2018, Is neoadjuvant chemoradiation with dose-escalation and consolidation chemotherapy sufficient to increase surgery-free and distant metastases-free survival in baseline cT3 rectal cancer?, Eur. J. Surg. Oncol., 44, 93, 10.1016/j.ejso.2017.11.010 Dossa, 2017, A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis, Lancet Gastroenterol Hepatol, 2, 501, 10.1016/S2468-1253(17)30074-2 Duldulao, 2013, Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer, Dis. Colon Rectum, 56, 142, 10.1097/DCR.0b013e31827541e2 Ryan, 2016, Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review, Colorectal Dis., 18, 234, 10.1111/codi.13207 Smith, 2014, Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy, Dis. Colon Rectum, 57, 311, 10.1097/DCR.0b013e3182a84eba Smith, 2012, The surgical significance of residual mucosal abnormalities in rectal cancer following neoadjuvant chemoradiotherapy, Br. J. Surg., 99, 993, 10.1002/bjs.8700 Rullier, 2017, Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial, Lancet, 390, 469, 10.1016/S0140-6736(17)31056-5 Rullier, 2020, Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial, Lancet Gastroenterol Hepatol, 5, 465, 10.1016/S2468-1253(19)30410-8 Morino, 2013, Previous transanal endoscopic microsurgery for rectal cancer represents a risk factor for an increased abdominoperineal resection rate, Surg. Endosc., 27, 3315, 10.1007/s00464-013-2911-x Perez, 2016, Transanal endoscopic microsurgery (TEM) following neoadjuvant chemoradiation for rectal cancer: outcomes of salvage resection for local recurrence, Ann. Surg Oncol., 23, 1143, 10.1245/s10434-015-4977-2